Contact

We welcome your inquiries and feedback. Please contact David Rozzell, CEO of Catylix, Inc. at the following e-mail address:

david.rozzell@catylix.com

Tel: +1-818-388-6576

Fax: +1-818-841-0011

{ 4 comments… read them below or add one }

Sharon Semones August 1, 2011 at 4:35 pm

Have you heard about Lilly’s Open Innovation Drug Discovery Program, whereby small biotechs can access Lilly’s Phenotypic and a some target based biological screens for FREE? Learn more at https://openinnovation.lilly.com/dd/ Also, contact me and I can provide you with an executive summary of the project.

Reply

catylixinc August 18, 2011 at 8:46 pm

Thanks, Sharon. We will follow up with you.

Reply

Alastair Lennox October 31, 2011 at 11:33 am

Hello,
Your reagent is obviously stoichometric in copper. This is not good. Do you have plans/ideas on how to make it catalytic in copper with a different CF3 donating reagent?

Thanks

Reply

catylixinc December 6, 2011 at 3:18 pm

Alastair, we are considering opportunities to make the reaction catalytic. The reagent can also be generated in situ and used immediately. For now, the convenience of a shelf-stable reagent that reacts quickly at near ambient conditions is a big advantage. In addition, the broad compatibility with most other chemical functionality offers a good option for late-stage trifluoromethylation, something that is difficult to do using other methods.

Reply

Leave a Comment